Results 91 to 100 of about 85,921 (270)

The Incidence and Characteristics of Oral Candidiasis in Patients Hospitalized for SARS-CoV-2 Infection During the Circulation of Alpha, Beta, and Delta Variants

open access: yesMicroorganisms
Background: Oral candidiasis has been documented in patients with SARS-CoV-2 infection, with varying prevalence rates across geographic regions and patient demographics.
Elena Camelia Kouris   +3 more
doaj   +1 more source

Intractable hiccups caused by esophageal diverticular candidiasis in an immunocompetent adult: a case report

open access: yes, 2017
Shinsuke Yahata,1,2 Tsuneaki Kenzaka,1 Saeko Kushida,3 Hogara Nishisaki,2 Hozuka Akita2 1Division of Community Medicine and Career Development, Kobe University Graduate School of Medicine, Kobe, 2Department of Internal Medicine, Hyogo Prefectural Kaibara
Nishisaki H   +4 more
core  

Nystatin Profile on Candida Species in HIV/AIDS Patients with Oral Candidiasis: A Phenomenology Study [PDF]

open access: yes, 2019
Oral candidiasis is the main symptom that often appears in patients with Human Immunodeficiency Virus (HIV) / Acquired Immune Syndrome (AIDS). Recent studies reported that some bacteria causing oral candidiasis are resistant to antifungal drugs ...
Dwi Murtiastutik   +7 more
core   +1 more source

A longitudinal study of avian pox in a small passerine, the Dunnock (Prunella modularis)

open access: yesIbis, EarlyView.
Long‐term, longitudinal studies of disease in wild bird populations are rare. Diseases are important determinants of bird survival and may spill‐over into other species including livestock and, in some cases, humans. Avian pox is a globally distributed disease, resulting from infection by viruses in the genus Avipoxvirus (APV).
Denise C. Wawman   +5 more
wiley   +1 more source

Risk of candidiasis associated with interleukin-17 inhibitors: Implications and management

open access: yesMycology
The application of interleukin-17 (IL-17) inhibitors, including secukinumab, ixekizumab, brodalumab, and bimekizumab, are associated with elevated risk of candidiasis. These medications interfere with the IL-17 pathway, which is essential for maintaining
Hazrat Bilal   +17 more
doaj   +1 more source

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis

open access: yes, 2009
Nathan P Wiederhold1, Jason M Cota2, Christopher R Frei11University of Texas at Austin College of Pharmacy, Austin, Texas, USA; 2University of the Incarnate Word Feik School of Pharmacy, San Antonio, Texas, USAAbstract: Micafungin is an echinocandin ...
Christopher R Frei   +2 more
core  

Candidiasis mucocutánea: espectro clínico [PDF]

open access: yes, 2019
Mucocutaneous candidiasis is a superficial infection very common in our environment, with multiple risk factors for its development. In recent decades its presentation has increased since it is strongly associated with HIV/AIDS, but it may also present ...
Palacios, Claudia Patricia   +2 more
core  

Integrating Supragingival Scaling and Biofilm Management Into Breast Cancer Patients' Care

open access: yesInternational Journal of Dental Hygiene, EarlyView.
ABSTRACT Objective The study was designed as a quasi‐experimental clinical trial to evaluate the impact of chemotherapy on periodontal conditions, haematology and salivary flow in patients with breast cancer and gingivitis, after supragingival scaling.
Kelly R. V. Villafuerte   +4 more
wiley   +1 more source

THE INCIDENCE OF ORAL CANDIDIASIS IN DIABETES

open access: yes, 2018
Background: this study was done in order to find of the frequency of oral fungal infection associated with diabetes type 2 and its correlation with the age, gender, glycemic control, timespan of illness and kind of therapy.
Dr. Ahmad Farooq, Dr. Khadija, Dr. Ayesha Younas
core   +1 more source

Candidiasis in Malignancy [PDF]

open access: yes, 2006
Esophageal candidiasis presents with a range of clinical findings and is rarely found among immunocompetent patient without predisposing factors. Between 20-50% of patient may be asymptomatic.
Abdullah, Murdani   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy